Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin with or without clopidogrel for prevention of recurrent transient ischemic attack or acute minor stroke
IRCT20120215009014N232Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin and clopidogrel in transient ischaemic attack (TIA) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: transient ischemic attack and acute minor stroke. Started Jul 2018; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
transient ischaemic attack (TIA)
Beyond the preview
Go deeper on IRCT20120215009014N232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N232.